Freeze-Dried Bone Allograft (FDBA)

Preclinical

Freeze-Dried Bone Allograft (FDBA) is one of 3 therapeutic programs targeting Tooth Extraction. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Tooth ExtractionCompleted

Tooth ExtractionPreclinical

Completed

Competition

Competitive Landscape

2 competitors in Tooth Extraction

#DrugCompanyPhaseTrials

Decadron

AAspen Global Incorporated

Approved

1 2

Coenzyme Q10

MMclean Hospital

Phase 3

1 3

Freeze-Dried Bone Allograft (FDBA)

AAnkara Yildirim Beyazıt University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Tooth Extraction1 trial

Clinical and Histological Evaluation of the Efficacy of Autogenous Dentin Graft in Extraction Socket Preservation

Completed·AAnkara Yildirim Beyazıt University·Preclinical·NCT07789262·9 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Freeze-Dried Bone Allograft (FDBA). U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Freeze-Dried Bone Allograft (FDBA). EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Ankara Yildirim Beyazıt University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: AAnkara Yildirim Beyazıt University

Freeze-Dried Bone Allograft (FDBA)

Status by Indication[2][1]

Competitive Landscape

Trials by Indication[1]

Tooth Extraction1 trial

References

Drug Info

Quick Facts

Related News